Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by McNeil Consumer Healthcare LLC
Lobbying Relationship
Bills mentioned
H.R.1078: Food and Drug Administration Safety Over Sequestration Act of 2015
Sponsor: Leonard Lance (R-N.J.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.3250: DXM Abuse Prevention Act of 2015
Sponsor: Bill Johnson (R-Ohio)
S.2994: DXM Abuse Prevention Act of 2016
Sponsor: Bob Casey (D-Pa.)
S.1014: Personal Care Products Safety Act
Sponsor: Dianne Feinstein (D-Calif.)
S.277: Strengthening Research in Adult Education Act
Sponsor: Jack Reed (D-R.I.)
S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act
Sponsor: Tom Udall (D-N.M.)
H.R.2858: Humane Cosmetics Act
Sponsor: Martha McSally (R-Ariz.)
S.957: Drug Supply Chain Security Act
Sponsor: Michael Bennet (D-Colo.)
H.R.1919: Safeguarding America's Pharmaceuticals Act of 2013
Sponsor: Robert E. Latta (R-Ohio)
S.959: Pharmaceutical Quality, Security, and Accountability Act
Sponsor: Tom Harkin (D-Iowa)
H.R.2359: Julia Carson Responsible Fatherhood and Healthy Families Act of 2013
Sponsor: Danny K. Davis (D-Ill.)
H.R.1483: Stop Outsourcing Banking Enforcement and Examination Act
Sponsor: Maxine Waters (D-Calif.)
H.R.2359: Safe Cosmetics Act of 2011
Sponsor: Jan Schakowsky (D-Ill.)
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.1483: Drug Safety Enhancement Act of 2011
Sponsor: John D. Dingell (D-Mich.)
H.R.4083: To suspend temporarily the duty on polyoxethylene-/alkyletherphosphate.
Sponsor: Charlie Dent (R-Pa.)
S.2317: A bill to extend temporarily the suspension of duty on...
Sponsor: Sherrod Brown (D-Ohio)
H.R.759: Food and Drug Administration Globalization Act of 2009
Sponsor: John D. Dingell (D-Mich.)
H.R.1259: Death Tax Repeal Permanency Act of 2011
Sponsor: Kevin Brady (R-Texas)
H.R.2923: Josh Birchfield Security Contractor Oversight Improvement Act
Sponsor: Joe Donnelly (D-Ind.)
H.R.5786: To suspend temporarily the duty on...
Sponsor: Robert Dold (R-Ill.)
H.R.4213: Unemployment Compensation Extension Act of 2010
Sponsor: Charles B. Rangel (D-N.Y.)
S.882: Drug and Device Accountability Act of 2009
Sponsor: Edward M. Kennedy (D-Mass.)
H.R.5740: To provide for the mandatory recall of adulterated or misbranded drugs.
Sponsor: Edolphus Towns (D-N.Y.)
H.R.1259: Dextromethorphan Distribution Act of 2009
Sponsor: Fred Upton (R-Mich.)
S.1383: Dextromethorphan Abuse Reduction Act of 2009
Sponsor: Richard J. Durbin (D-Ill.)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.4872: Health Care and Education Reconciliation Act of 2010
Sponsor: John M. Spratt Jr. (D-S.C.)
H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...
Sponsor: John D. Dingell (D-Mich.)
H.R.4083: Non-Prescription Drug Modernization Act of 2007
Sponsor: Henry A. Waxman (D-Calif.)
S.2317: Intellectual Property Enforcement Act of 2007
Sponsor: Patrick J. Leahy (D-Vt.)
H.R.3610: Food and Drug Import Safety Act of 2007
Sponsor: John D. Dingell (D-Mich.)
S.3409: Drug and Device Accountability Act of 2008
Sponsor: Edward M. Kennedy (D-Mass.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Barrett Thornhill | Senator Crapo staff |
| Paul Kim | Senator Kennedy Director for Health Policy; Congressman |
| Kelly Childress | Congressman Rogers staff; Congressman Shimkus staff |
| - - | Waxman counsel; Senator Pryor staff Asst; Sen Charles Schumer, Dir Econ Dev&Approp |
| Kevin Brennan | Chief of Staff for Rep. Rosa DeLauro |
| Dayle Lewis Cristinzio | Sen Harry Reid, Leg Dir; Rep Steny Hoyer, Sr Leg |
| Kalah Auchincloss | n/a |
| Andrew London | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate